Kaplan‐Meier analysis using the mean GRIK3 expression score of 52 breast cancer samples as a cutoff point revealed that higher GRIK3 expression in 32 clinical patients with breast cancer was positively correlated with lower survival probability, whereas lower GRIK3 expression in 20 clinical patients with breast cancer showed a negative correlation (https://precog.stanford.edu/; Figure 1F). The gene discussed is GRIK3; the disease is breast cancer.